The Smith laboratory is developing a new, ultrahigh-resolution immunoimaging method called Array Tomography. By permitting three-dimensional visualization of
biomolecular architectures with unprecedented clarity, this new method fills important gaps in previous abilities
to analyze cells and tissues and to diagnose human illness. Array tomography is proteomic in scope, being capable of imaging
an almost unlimited number of distinct cellular molecules in individual specimens, and improves greatly
upon existing immunofluorescence microscopy techniques in quantitative reliability, spatial resolution,
sensitivity and specificity. Array tomography complements dynamic
in vivo imaging methods,
including those based on the use of expressed fluorescent proteins, by providing efficient means for
retrospective immunoanalysis of dynamically imaged specimens. In addition, array tomography will enable exploration of
the most intricate tissue architectures, such as the brain’s synaptic circuitry, that have proved largely
intractable to existing methods. To learn more about Array Tomography visit the
Stanford Array Tomography Resource (SATR) website.